MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
12.97
-0.03 (-0.23%)
Aug 25, 2026, 4:00 PM EDT - Market closed
MediWound Market Cap
MediWound has a market cap or net worth of $167.45 million as of August 25, 2026. Its market cap has decreased by -12.54% in one year.
Market Cap
167.45M
Enterprise Value
140.71M
1-Year Change
-12.54%
Ranking
Category
Stock Price
$12.97
ChartMarket Cap Chart
Since March 20, 2014, MediWound's market cap has decreased from $262.70M to $167.45M, a decrease of -36.26%. That is a compound annual growth rate of -3.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 167.45M | -29.25% |
| Dec 31, 2025 | 236.68M | 23.23% |
| Dec 31, 2024 | 192.06M | 104.85% |
| Dec 29, 2023 | 93.76M | 19.44% |
| Dec 30, 2022 | 78.50M | 22.08% |
| Dec 31, 2021 | 64.30M | -36.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nkarta | 185.51M |
| Humacyte | 183.96M |
| Codexis | 181.78M |
| Caribou Biosciences | 175.82M |
| Canton Strategic Holdings | 170.52M |
| Spruce Biosciences | 168.56M |
| Cue Biopharma | 168.39M |
| Molecular Partners AG | 165.16M |